Literature DB >> 29044292

Investigation of the Filamin A-Dependent Mechanisms of Tissue Factor Incorporation into Microvesicles.

Mary E W Collier1, Camille Ettelaie2, Benjamin T Goult3, Anthony Maraveyas4, Alison H Goodall1.   

Abstract

We have previously shown that phosphorylation of tissue factor (TF) at Ser253 increases the incorporation of TF into microvesicles (MVs) following protease-activated receptor 2 (PAR2) activation through a process involving filamin A, whereas phosphorylation of TF at Ser258 suppresses this process. Here, we examined the contribution of the individual phosphorylation of these serine residues to the interaction between filamin A and TF, and further examined how filamin A regulates the incorporation of TF into MVs. In vitro binding assays using recombinant filamin A C-terminal repeats 22-24 with biotinylated phospho-TF cytoplasmic domain peptides as bait showed that filamin A had the highest binding affinities for phospho-Ser253 and double-phosphorylated TF peptides, while the phospho-Ser258 TF peptide had the lowest affinity. Analysis of MDA-MB-231 cells using an in situ proximity ligation assay revealed increased proximity between the C-terminus of filamin A and TF following PAR2 activation, which was concurrent with Ser253 phosphorylation and TF-positive MV release from these cells. Knock-down of filamin A expression suppressed PAR2-mediated increases in cell surface TF procoagulant activity without reducing cell surface TF antigen expression. Disrupting lipid rafts by pre-incubation with methyl-β-cyclodextrin prior to PAR2 activation reduced TF-positive MV release and cell surface TF procoagulant activity to the same extent as filamin A knock-down. In conclusion, this study shows that the interaction between TF and filamin A is dependent on the differential phosphorylation of Ser253 and Ser258. Furthermore, the interaction of TF with filamin A may translocate cell surface TF to cholesterol-rich lipid rafts, increasing cell surface TF activity as well as TF incorporation and release into MVs. Schattauer GmbH Stuttgart.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29044292     DOI: 10.1160/TH17-01-0009

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Filamin-A expression in laryngeal squamous cell carcinoma and its clinical significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-10-22       Impact factor: 2.303

Review 2.  Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis.

Authors:  Rosa Suades; Maria Francesca Greco; Teresa Padró; Lina Badimon
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

Review 3.  Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.

Authors:  Lina Badimon; Rosa Suades; Gemma Arderiu; Esther Peña; Gemma Chiva-Blanch; Teresa Padró
Journal:  Front Cardiovasc Med       Date:  2017-12-18

4.  Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities.

Authors:  Mohammad A Mohammad; John Greenman; Anthony Maraveyas; Camille Ettelaie
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

Review 5.  The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Authors:  Alicia S Eustes; Sanjana Dayal
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 6.  Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Br J Cancer       Date:  2022-09-12       Impact factor: 9.075

Review 7.  Actin and Actin-Associated Proteins in Extracellular Vesicles Shed by Osteoclasts.

Authors:  L Shannon Holliday; Lorraine Perciliano de Faria; Wellington J Rody
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.